journal article·2021-09Open access

Long term expansion profile of mesenchymal stromal cells at protein nanosheet-stabilised bioemulsions for next generation cell culture microcarriers

Lihui Peng, Julien E. Gautrot

Abstract

Tremendous progress in the identification, isolation and expansion of stem cells has allowed their application in regenerative medicine and tissue engineering, and their use as advanced in vitro models. As a result, stem cell manufacturing increasingly requires scale up, parallelisation and automation. However, solid substrates currently used for the culture of adherent cells are poorly adapted for such applications, owing to their difficult processing from cell products, relatively high costs and their typical reliance on difficult to recycle plastics and microplastics. In this work, we show that bioemulsions formed of microdroplets stabilised by protein nanosheets displaying strong interfacial mechanics are well-suited for the scale up of adherent stem cells such as mesenchymal stromal cells (MSCs). We demonstrate that, over multiple passages (up to passage 10), MSCs retain comparable phenotypes when cultured on such bioemulsions, solid microcarriers (Synthemax II) and classic 2D tissue culture polystyrene. Phenotyping (cell proliferation, morphometry, flow cytometry and differentiation assays) of MSCs cultured for multiple passages on these systems indicate that, although stemness is lost at late passages when cultured on these different substrates, stem cell phenotypes remained comparable between different culture conditions, at any given passage. Hence our study validates the use of bioemulsions for the long term expansion of adherent stem cells and paves the way to the design of novel 3D bioreactors based on microdroplet microcarriers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Mesenchymal stem cell research · Cellular Mechanics and Interactions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (91)

Show source-provided references
1. Radiosensitivity and postirradiation changes of bone marrow clonogenic stromal mechanocytes
2. Clinical applications of mesenchymal stem cells
3. Human mesenchymal stem cells - current trends and future prospective10.1042/BSR20150025 ↗
4. Mesenchymal stem cells: a new trend for cell therapy10.1038/aps.2013.50 ↗
5. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement10.1080/14653240600855905 ↗
6. Human mesenchymal stem cells retain multilineage differentiation capacity including neural marker expression after extended in vitro expansion10.1371/journal.pone.0137255 ↗
7. Improved expansion of human bone marrow-derived mesenchymal stem cells in microcarrier-based suspension culture
8. Microcarrier choice and bead-to-bead transfer for human mesenchymal stem cells in serum-containing and chemically defined media10.1016/j.procbio.2017.03.017 ↗
9. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use
10. You · 2020 · 120356
11. Transplantation of ACE2- Mesenchymal stem cells improves the outcome of patients with covid-19 pneumonia10.14336/AD.2020.0228 ↗
12. Mesenchymal stem cells and management of COVID-19 pneumonia10.1016/j.medidd.2020.100019 ↗
13. Wharton's jelly-derived mesenchymal stromal cells as a promising cellular therapeutic strategy for the management of graft-versus-host disease10.3390/ph8020196 ↗
14. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study10.1016/S0140-6736(08)60690-X ↗
15. Large-scale production of stem cells utilizing microcarriers: a biomaterials engineering perspective from academic research to commercialized products10.1016/j.biomaterials.2018.07.016 ↗
16. Bioreactor design for clinical-grade expansion of stem cells10.1002/biot.201200373 ↗
17. Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactors10.1002/biot.201400862 ↗
18. Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction10.1016/j.biotechadv.2013.03.006 ↗
19. Qualitative and quantitative demonstration of bead-to-bead transfer with bone marrow-derived human mesenchymal stem cells on microcarriers: utilising the phenomenon to improve culture performance10.1016/j.bej.2017.11.005 ↗
20. Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a review10.1186/s13287-015-0228-5 ↗
21. Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems10.1016/j.jbiotec.2016.07.023 ↗
22. Manufacturing of human umbilical cord mesenchymal stromal cells on microcarriers in a dynamic system for clinical use
23. A microcarrier-based cultivation system for expansion of primary mesenchymal stem cells10.1021/bp060155w ↗
24. Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system10.1016/j.jbiotec.2010.02.015 ↗
25. Suspension culture of mammalian cells using thermosensitive microcarrier that allows cell detachment without proteolytic enzyme treatment10.3727/096368910X516664 ↗
26. Advances and challenges in stem cell culture10.1016/j.colsurfb.2017.07.051 ↗
27. Scale-up of human mesenchymal stem cell culture: current technologies and future challenges10.1016/j.coche.2013.01.005 ↗
28. Long term expansion of bone marrow-derived hMSCs on novel synthetic microcarriers in xeno-free, defined conditions10.1371/journal.pone.0092120 ↗
29. Synthetic surface for expansion of human mesenchymal stem cells in xeno-free, chemically defined culture conditions10.1371/journal.pone.0070263 ↗
30. A potentially scalable method for the harvesting of hMSCs from microcarriers10.1016/j.bej.2014.02.005 ↗
31. Tissue engineering based on cell sheet technology10.1002/adma.200701978 ↗
32. Cell sheet technology: a promising strategy in regenerative medicine10.1016/j.jcyt.2018.10.013 ↗
33. Dissolvable microcarriers allow scalable expansion and harvesting of human induced pluripotent stem cells under xeno-free conditions10.1002/biot.201800461 ↗
34. Expansion of human mesenchymal stem/stromal cells on temporary liquid microcarriers
35. A review on continuous-flow microfluidic PCR in droplets: advances, challenges and future10.1016/j.aca.2016.02.006 ↗
36. Monodisperse uni- and multicompartment liposomes10.1021/jacs.6b02107 ↗
37. Growth factors, matrices, and forces combine and control stem cells10.1126/science.1171643 ↗
38. Control of stem cell fate by physical interactions with the extracellular matrix10.1016/j.stem.2009.06.016 ↗
39. Force loading explains spatial sensing of ligands by cells10.1038/nature24662 ↗
40. Extracellular-matrix tethering regulates stem-cell fate
41. Cardiomyocytes sense matrix rigidity through a combination of muscle and non-muscle myosin contractions10.1016/j.devcel.2017.12.024 ↗
42. Actin and serum response factor transduce physical cues from the microenvironment to regulate epidermal stem cell fate decisions10.1038/ncb2074 ↗
43. Role of YAP/TAZ in mechanotransduction10.1038/nature10137 ↗
44. Cell growth on liquid microcarriers10.1126/science.6828872 ↗
45. Cell growth on liquid interfaces: role of surface active compounds10.1073/pnas.80.18.5622 ↗
46. The culture of HaCaT cells on liquid substrates is mediated by a mechanically strong liquid-liquid interface10.1039/C7FD00091J ↗
47. Protein nanosheet mechanics controls cell adhesion and expansion on low-viscosity liquids10.1021/acs.nanolett.7b05339 ↗
48. Stem cell expansion and fate decision on liquid substrates are regulated by self-assembled nanosheets10.1021/acsnano.8b03865 ↗
49. Behavior of cells at fluid interfaces10.1073/pnas.80.1.219 ↗
50. Substrate mechanics and cell spreading10.1016/0014-4827(91)90406-K ↗
51. Morphology and growth of mammalian cells in a liquid/liquid culture system supported with oxygenated perfluorodecalin10.1007/s10529-013-1218-2 ↗
52. Suppression of myogenic differentiation of mammalian cells caused by fluidity of a liquid-liquid interface10.1021/acsami.7b11445 ↗
53. Adaptive liquid interfacially assembled protein nanosheets for guiding mesenchymal stem cell fate10.1002/adma.201905942 ↗
54. Microdroplets: a sea of applications?10.1039/b806405a ↗
55. Replicative senescence of mesenchymal stem cells: a continuous and organized process10.1371/journal.pone.0002213 ↗
56. Senescence in mesenchymal stem cells: functional alterations, molecular mechanisms, and rejuvenation strategies
57. Senescence of mesenchymal stem cells (Review)10.3892/ijmm.2017.2912 ↗
58. Cytoskeleton-based forecasting of stem cell lineage fates10.1073/pnas.0909597107 ↗
59. Senescence in human mesenchymal stem cells: functional changes and implications in stem cell-based therapy10.3390/ijms17071164 ↗
60. A comprehensive review on mesenchymal stem cell growth and senescence10.1089/rej.2009.0830 ↗
61. Membrane ruffles in cell migration: indicators of inefficient lamellipodia adhesion and compartments of actin filament reorganization10.1016/j.yexcr.2004.08.034 ↗
62. Functions and regulation of circular dorsal ruffles10.1128/MCB.00551-12 ↗
63. New insights into the formation and the function of lamellipodia and ruffles in mesenchymal cell migration
64. Mechanical integration of actin and adhesion dynamics in cell migration10.1146/annurev.cellbio.011209.122036 ↗
65. Transmembrane extracellular matrix-cytoskeleton crosstalk10.1038/35099066 ↗
66. Thy-1: more than a marker for mesenchymal stromal cells10.1096/fj.201802224R ↗
67. An accessory component of the TGF-β-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies10.1002/jcp.1095 ↗
68. Osteogenic potential of mouse periosteum-derived cells sorted for CD90 in vitro and in vivo, stem cells transl
69. Down-regulation of CD105 is associated with multi-lineage differentiation in human umbilical cord blood-derived mesenchymal stem cells10.1016/j.bbrc.2009.02.118 ↗
70. Long term exposure to myrtucommulone-A changes CD105 expression and differentiation potential of mesenchymal stem cells10.1007/s13770-016-0020-3 ↗
71. Expression of CD105 on expanded mesenchymal stem cells does not predict their chondrogenic potential10.1016/j.joca.2015.11.018 ↗
72. Flow cytometry and compensation of highly autofluorescent cells: the example of mesenchymal stem cells10.7243/2054-717X-2-4 ↗
73. Autofluorescence is a reliable in vitro marker of cellular senescence in human mesenchymal stromal cells10.1038/s41598-019-38546-2 ↗
74. Matrix elasticity directs stem cell lineage specification10.1016/j.cell.2006.06.044 ↗
75. Evidences for correlation between the reduced VCAM-1 expression and hyaluronan synthesis during cellular senescence of human mesenchymal stem cells10.1016/j.bbrc.2010.12.003 ↗
76. Markers for characterization of bone marrow multipotential stromal cells
77. The role of alkaline phosphatase in mineralization10.1097/BCO.0b013e3282630851 ↗
78. Osteoblast differentiation at a glance10.12659/MSMBR.901142 ↗
79. Fate of growth plate hypertrophic chondrocytes: death or lineage extension?10.1111/dgd.12203 ↗
80. The sequential expression profiles of growth factors from osteroprogenitors to osteoblasts in vitro10.1089/ten.2006.0423 ↗
81. Bone morphogenetic protein-2 stimulates Runx2 acetylation10.1074/jbc.M512494200 ↗
82. Spherical bioactive glass particles and their interaction with human mesenchymal stem cells in vitro10.1016/j.biomaterials.2010.08.082 ↗
83. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F ↗
84. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate10.1046/j.1365-2141.1999.01715.x ↗
85. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components10.1006/excr.2001.5278 ↗
86. Endochondral ossification: how cartilage is converted into bone in the developing skeleton10.1016/j.biocel.2007.06.009 ↗
87. The role of type X collagen in facilitating and regulating endochondral ossification of articular cartilage10.1111/j.1601-6343.2004.00308.x ↗
88. Extreme reversal in mechanical anisotropy in liquid-liquid interfaces reinforced with self-assembled protein nanosheets10.1016/j.jcis.2021.03.055 ↗
89. Effect of trypsin culture cells on the cell surface proteins of hepatoma tissue culture cells10.1016/S0021-9258(18)50677-3 ↗
90. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression10.1016/0092-8674(93)90251-K ↗
91. Comparative immunophenotyping of equine multipotent mesenchymal stromal cells: an approach toward a standardized definition10.1002/cyto.a.22491 ↗